1. 27: Management and outcomes of patients with non-small cell lung cancer (NSCLC) and synchronous brain metastases: A multicentre retrospective review. (January 2017) Authors: Cook, M.; Allos, B.; O'Beirn, M.; Denley, S.; Homer, K.; Sabel, L.; Jegannathen, A.; Chatterjee, A.; Koh, P. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK. Issue 1 (January 2022) Authors: Banfill, K.; Croxford, W.; Fornacon-Wood, I.; Wicks, K.; Ahmad, S.; Britten, A.; Carson, C.; Dorey, N.; Hatton, M.; Hiley, C.; Thippu Jayaprakash, K.; Jegannathen, A.; Koh, P.; Panakis, N.; Peedell, C.; Pope, A.; Powell, C.; Stilwell, C.; Thomas, B.; Toy, E. Journal: Clinical oncology Issue: Volume 34:Issue 1(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer. (May 2021) Authors: Haslett, K.; Koh, P.; Hudson, A.; Ryder, W.D.; Falk, S.; Mullan, D.; Taylor, B.; Califano, R.; Blackhall, F.; Faivre-Finn, C. Journal: Clinical and translational radiation oncology Issue: Volume 28(2021) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0753: Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC. (April 2018) Authors: Haslett, K.; Blackhall, F.; Koh, P.; Ashcroft, L.; Asselin, M.; Harris, C.; Jackson, A.; Manoharan, P.; Mullan, D.; Ryder, W.; Taylor, B.; Faivre-Finn, C. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗